Largest health care companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
UnitedHealth Group leads the 170 health care companies ranked by cash on hand, at CHF 20.5B, ahead of Johnson & Johnson (CHF 16.6B) and Centene (CHF 15.1B). Figures as of 20 Nov 2026, 05:42 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- UnitedHealth GroupCHF 20.5B
- Median
- CHF 488.9M
- Combined market value
- CHF 7.51T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Cash on hand ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | Merit Medical SystemsMMSI · Health Care | CHF 376M | CHF 4.3B | CHF 71.09 | 1.77% down | 1% up | ||
| 102 | STERISSTE · Health Care | CHF 370.2M | CHF 20.8B | CHF 214.56 | 1.85% down | 1% up | ||
| 103 | Quest DiagnosticsDGX · Health Care | CHF 353.7M | CHF 24B | CHF 218.21 | 0.23% down | 38% up | ||
| 104 | AlkermesALKS · Health Care | CHF 327.3M | CHF 6.5B | CHF 38.89 | 1.43% down | 66% up | ||
| 105 | Revolution MedicinesRVMD · Health Care | CHF 323.2M | CHF 29B | CHF 134.28 | 0.24% down | 129% up | ||
| 106 | Bausch + LombBLCO · Health Care | CHF 322.6M | CHF 6.2B | CHF 17.43 | 1.24% down | 44% up | ||
| 107 | TeleflexTFX · Health Care | CHF 318.8M | CHF 5.5B | CHF 137.62 | 1.48% down | 58% up | ||
| 108 | Guardant HealthGH · Health Care | CHF 318.5M | CHF 16.6B | CHF 122.62 | 0.31% up | 45% up | ||
| 109 | Ionis PharmaceuticalsIONS · Health Care | CHF 313.5M | CHF 3.8B | CHF 22.93 | 0.62% down | 63% down | ||
| 110 | AvantorAVTR · Health Care | CHF 307.7M | CHF 8.6B | CHF 12.73 | 1.63% down | 40% up | ||
| 111 | Lantheus HoldingsLNTH · Health Care | CHF 302.5M | CHF 5.6B | CHF 85.99 | 0.10% up | 90% up | ||
| 112 | Praxis Precision MedicinesPRAX · Health Care | CHF 300.9M | CHF 7.3B | CHF 261.85 | 1.87% up | 86% up | ||
| 113 | Kymera TherapeuticsKYMR · Health Care | CHF 300.7M | CHF 8.6B | CHF 100.55 | 1.44% down | 87% up | ||
| 114 | Belite BioBLTE · Health Care | CHF 297.2M | CHF 5.2B | CHF 127.19 | 3.33% down | 43% up | ||
| 115 | CRISPR TherapeuticsCRSP · Health Care | CHF 292.7M | CHF 3.2B | CHF 32.79 | 3.14% down | 18% down | ||
| 116 | Scholar Rock HoldingSRRK · Health Care | CHF 272.5M | CHF 5.2B | CHF 42.42 | 4.94% up | 26% up | ||
| 117 | Axsome TherapeuticsAXSM · Health Care | CHF 272M | CHF 6B | CHF 114.27 | 1.25% up | 6% down | ||
| 118 | HealthEquityHQY · Health Care | CHF 268.6M | CHF 6.8B | CHF 82.02 | 0.07% up | 3% down | ||
| 119 | Cogent BiosciencesCOGT · Health Care | CHF 262.8M | CHF 4.1B | CHF 23.36 | 0.25% down | 20% down | ||
| 120 | BrukerBRKR · Health Care | CHF 251.7M | CHF 8B | CHF 52.30 | 1.83% down | 44% up | ||
| 121 | MiniMed GroupMMED · Health Care | CHF 251M | CHF 3.9B | CHF 13.69 | 4.30% down | 8% down | ||
| 122 | Mirum PharmaceuticalsMIRM · Health Care | CHF 249.9M | CHF 5.3B | CHF 80.44 | 3.27% up | 34% up | ||
| 123 | Amneal PharmaceuticalsAMRX · Health Care | CHF 237.5M | CHF 6.3B | CHF 18.02 | 2.24% down | 90% up | ||
| 124 | Bio-TechneTECH · Health Care | CHF 222.9M | CHF 9.6B | CHF 61.23 | 0.07% down | 24% up | ||
| 125 | Definium TherapeuticsDFTX · Health Care | CHF 217.2M | CHF 3.4B | CHF 24.83 | 1.24% up | 168% up | ||
| 126 | GRAILGRAL · Health Care | CHF 210.3M | CHF 4B | CHF 88.30 | 2.68% up | 19% up | ||
| 127 | LifeStance Health GroupLFST · Health Care | CHF 209.4M | CHF 4.3B | CHF 11.24 | 3.12% down | 123% up | ||
| 128 | HaemoneticsHAE · Health Care | CHF 206.7M | CHF 4.6B | CHF 101.38 | 2.03% down | 64% up | ||
| 129 | Option Care HealthOPCH · Health Care | CHF 195.9M | CHF 4B | CHF 26.62 | 0.32% down | 12% up | ||
| 130 | Hims & Hers HealthHIMS · Health Care | CHF 192.5M | CHF 3.2B | CHF 13.49 | 6.04% down | 49% down | ||
| 131 | Arrowhead PharmaceuticalsARWR · Health Care | CHF 190.8M | CHF 5.2B | CHF 36.76 | 1.25% up | 13% up | ||
| 132 | Summit TherapeuticsSMMT · Health Care | CHF 189.7M | CHF 7.1B | CHF 8.90 | 0.67% up | 36% down | ||
| 133 | Charles River Laboratories InternationalCRL · Health Care | CHF 180M | CHF 13.2B | CHF 276.19 | 1.60% down | 106% up | ||
| 134 | Kodiak SciencesKOD · Health Care | CHF 176.7M | CHF 5.4B | CHF 82.45 | 0.09% up | 399% up | ||
| 135 | Madrigal PharmaceuticalsMDGL · Health Care | CHF 167.3M | CHF 7.8B | CHF 334.14 | 0.34% down | 27% down | ||
| 136 | PACS GroupPACS · Health Care | CHF 165.9M | CHF 5.8B | CHF 36.24 | 7.06% down | 77% up | ||
| 137 | PenumbraPEN · Health Care | CHF 157.4M | CHF 10.6B | CHF 269.52 | 0.18% down | 15% up | ||
| 138 | Twist BioscienceTWST · Health Care | CHF 154.2M | CHF 6.4B | CHF 94.01 | 4.07% down | 346% up | ||
| 139 | IDEXX LaboratoriesIDXX · Health Care | CHF 151.7M | CHF 45.8B | CHF 580.84 | 1.26% down | 1% up | ||
| 140 | Ligand PharmaceuticalsLGND · Health Care | CHF 147.3M | CHF 4.8B | CHF 241.67 | 3.94% down | 50% up | ||
| 141 | VaxcytePCVX · Health Care | CHF 146.5M | CHF 7.8B | CHF 49.15 | 0.27% down | 23% up | ||
| 142 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CHF 139.5M | CHF 6.2B | CHF 78.78 | 1.59% down | 129% up | ||
| 143 | MSA SafetyMSA · Health Care | CHF 139M | CHF 5.7B | CHF 148.43 | 0.68% down | 16% up | ||
| 144 | Dr. Reddy's LaboratoriesRDY · Health Care | CHF 137.7M | CHF 10.4B | CHF 12.49 | 1.00% down | 8% up | ||
| 145 | Henry ScheinHSIC · Health Care | CHF 131.4M | CHF 7.9B | CHF 71.42 | 1.04% down | 20% up | ||
| 146 | Universal Health ServicesUHS · Health Care | CHF 116.1M | CHF 8.5B | CHF 147.37 | 5.96% down | 17% down | ||
| 147 | Halozyme TherapeuticsHALO · Health Care | CHF 112.7M | CHF 8.9B | CHF 78.36 | 2.88% down | 39% up | ||
| 148 | Protagonist TherapeuticsPTGX · Health Care | CHF 108.1M | CHF 6.8B | CHF 104.45 | 2.47% down | 51% up | ||
| 149 | CytokineticsCYTK · Health Care | CHF 103.2M | CHF 6B | CHF 43.34 | 0.27% up | 19% down | ||
| 150 | Corcept TherapeuticsCORT · Health Care | CHF 101.5M | CHF 6B | CHF 54.73 | 4.15% down | 10% down | ||
| 151 | Cooper CompaniesCOO · Health Care | CHF 93.1M | CHF 9.7B | CHF 50.81 | 0.69% down | 15% down | ||
| 152 | Travere TherapeuticsTVTX · Health Care | CHF 78.4M | CHF 3.9B | CHF 40.68 | 3.86% down | 45% up | ||
| 153 | GlaukosGKOS · Health Care | CHF 76.5M | CHF 11.9B | CHF 200.53 | 2.15% up | 145% up | ||
| 154 | BrightSpring Health ServicesBTSG · Health Care | CHF 74.4M | CHF 10.7B | CHF 53.92 | 6.32% down | 109% up | ||
| 155 | ImmunityBioIBRX · Health Care | CHF 74.4M | CHF 5.9B | CHF 5.53 | 1.94% down | 232% up | ||
| 156 | Spyre TherapeuticsSYRE · Health Care | CHF 72.2M | CHF 7.8B | CHF 82.23 | 3.77% down | 332% up | ||
| 157 | Concentra Group Holdings ParentCON · Health Care | CHF 67.3M | CHF 4.4B | CHF 34.91 | 1.12% down | 116% up | ||
| 158 | TG TherapeuticsTGTX · Health Care | CHF 66.7M | CHF 8.3B | CHF 54.64 | 1.88% down | 117% up | ||
| 159 | ChemedCHE · Health Care | CHF 62.8M | CHF 6B | CHF 464.34 | 0.84% up | 27% up | ||
| 160 | ErascaERAS · Health Care | CHF 62.2M | CHF 4.2B | CHF 11.98 | 3.34% up | 395% up | ||
| 161 | Encompass HealthEHC · Health Care | CHF 60.8M | CHF 10.9B | CHF 111.41 | 1.96% down | 20% up | ||
| 162 | Adaptive BiotechnologiesADPT · Health Care | CHF 59.4M | CHF 3.8B | CHF 23.62 | 1.44% down | 74% up | ||
| 163 | Mettler-Toledo InternationalMTD · Health Care | CHF 56.3M | CHF 28.6B | CHF 1,436.54 | 1.82% down | 24% up | ||
| 164 | Edgewise TherapeuticsEWTX · Health Care | CHF 51.5M | CHF 3.8B | CHF 34.67 | 0.48% down | 86% up | ||
| 165 | Rhythm PharmaceuticalsRYTM · Health Care | CHF 45.7M | CHF 6.8B | CHF 98.37 | 1.88% down | 18% up | ||
| 166 | Dianthus TherapeuticsDNTH · Health Care | CHF 43M | CHF 4B | CHF 71.45 | 1.01% up | 108% up | ||
| 167 | Oruka TherapeuticsORKA · Health Care | CHF 39.5M | CHF 5.6B | CHF 82.18 | 1.91% up | 255% up | ||
| 168 | HeartflowHTFL · Health Care | CHF 37.7M | CHF 3.3B | CHF 37.59 | 2.75% down | 66% up | ||
| 169 | CG OncologyCGON · Health Care | CHF 27.4M | CHF 6.2B | CHF 68.98 | 2.38% up | 97% up | ||
| 170 | VeradermicsMANE · Health Care | CHF 18.3M | CHF 4.4B | CHF 104.76 | 0.38% down | 231% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8422 CHF).
Questions and answers
Which health care companies rank first by cash on hand?
UnitedHealth Group (CHF 20.5B), Johnson & Johnson (CHF 16.6B) and Centene (CHF 15.1B) are the top three of the 170 health care companies ranked by cash on hand as of 20 Nov 2026, 05:42 UTC.
How many health care companies are in this ranking?
170 are ranked by cash on hand.
What are these health care companies worth together?
The 170 health care companies ranked by cash on hand have a combined market value of CHF 7.51T as of 20 Nov 2026, 05:42 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care companies by cash on hand”, data as of 20 November 2026. https://funkfolio.com/companies/sector/health-care?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.